| First Author | Tamamura Y | Year | 2019 |
| Journal | Biochem Biophys Res Commun | Volume | 518 |
| Issue | 2 | Pages | 233-238 |
| PubMed ID | 31420162 | Mgi Jnum | J:291415 |
| Mgi Id | MGI:6444010 | Doi | 10.1016/j.bbrc.2019.08.038 |
| Citation | Tamamura Y, et al. (2019) Notch signaling is involved in Fgf23 upregulation in osteocytes. Biochem Biophys Res Commun 518(2):233-238 |
| abstractText | Fgf23 acts as a phosphaturic factor secreted from osteocytes in bone, but the mechanism regulating Fgf23 is not fully understood. Here, we showed the colocalization of Fgf23, Notch, and Hes1, a downstream target of Notch signaling, in numerous osteocytes in cortical bone of femur in wild-type mice. We generated NICD (Notch intracellular domain)-transgenic mice driven by a 2.3kb collagenalpha1 (I) (Col1a1) promoter fragment. Western blot and RT-PCR analyses revealed upregulation of Notch protein and mRNA levels in the bones of transgenic mice compared with those in wild-type mice. In the transgenic mice, immunohistochemical studies demonstrated that numerous osteocytes and osteoblasts express Notch in the rib, whereas only osteoblasts exhibit Notch in the femur. NICD-transgenic mice were characterized by upregulation of Fgf23 mRNA levels in the rib but not in the femur compared with that in wild type mice. These mice exhibited dwarfism associated with an osteomalacia phenotype. The expression of Alpl, Col1a1, and Bglap decreased in NICD-transgenic mice compared with wild-type mice. UMR-106cells cultured on Jagged1-immobilized wells significantly increased Fgf23 expressions associating with upregulation of Hes1 and Hey1. These results imply that Notch signaling is a positive regulator for Fgf23 expression in osteocytes. |
